Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 15 Total
PRME - Prime Medicine Inc - Stock Price Chart
TickerPRME [NASD, RUT]
CompanyPrime Medicine Inc
CountryUSA
IndustryBiotechnology
Market Cap845.01MEPS (ttm)-2.13
P/E-EPS this Y24.26%
Forward P/E-EPS next Y8.76%
PEG-EPS past 5Y-193.88%
P/S1432.22EPS next 5Y-
P/B3.47EPS Q/Q0.97%
Dividend-Sales Q/Q-
Insider Own58.50%Inst Own34.66%
Insider Trans15.84%Inst Trans-
Short Float21.84%EarningsMay 10/b
Analyst Recom1.36Target Price14.60
Avg Volume726.67K52W Range4.11 - 17.20
May-16-24Upgrade Citigroup Neutral → Buy $10
May-16-24 07:14AM Citigroup Upgrades Prime Medicine at Buy From Neutral With $10 Price Target (MT Newswires)
May-14-24 09:55AM Does Prime Medicine, Inc. (PRME) Have the Potential to Rally 133.64% as Wall Street Analysts Expect? (Zacks)
May-13-24 11:12AM JPMorgan Adjusts Price Target on Prime Medicine to $15 From $16, Keeps Overweight Rating (MT Newswires) +14.44%
08:00AM Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ (GlobeNewswire)
May-12-24 03:00AM Alphabet Bought Up Two Slumping Stocks (Barrons.com)
May-10-24 02:23PM Prime Medicine Inc (PRME) Q1 2024 Earnings: Navigates Through Challenges with Strategic Developments (GuruFocus.com)
01:53PM PRME Stock Earnings: Prime Medicine Beats EPS for Q1 2024 (InvestorPlace)
08:00AM Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire)
May-08-24 08:00AM Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD) (GlobeNewswire)
May-03-24 12:00PM What Makes Prime Medicine, Inc. (PRME) a New Buy Stock (Zacks)
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NELSEN ROBERTDirectorFeb 15 '24Buy6.253,200,00020,000,0003,200,000Feb 20 05:41 PM
ARCH Venture Partners X, LLC10% OwnerFeb 15 '24Buy6.253,200,00020,000,0003,200,000Feb 20 05:37 PM
ARCH Venture Partners XII, LLC10% OwnerFeb 15 '24Buy6.253,200,00020,000,0003,200,000Feb 20 05:38 PM
GV 2019 GP, L.L.C.10% OwnerJun 21 '23Sale14.9719,003284,4960Jun 22 05:03 PM
GV 2019 GP, L.L.C.10% OwnerJun 20 '23Sale15.0637,405563,2480Jun 22 05:03 PM
TRUP - Trupanion Inc - Stock Price Chart
TickerTRUP [NASD, RUT]
CompanyTrupanion Inc
CountryUSA
IndustryInsurance - Specialty
Market Cap1.38BEPS (ttm)-0.64
P/E-EPS this Y59.13%
Forward P/E-EPS next Y99.62%
PEG-EPS past 5Y-106.11%
P/S1.19EPS next 5Y-
P/B4.54EPS Q/Q72.88%
Dividend-Sales Q/Q19.43%
Insider Own25.97%Inst Own95.69%
Insider Trans0.06%Inst Trans4.90%
Short Float39.82%EarningsMay 02/a
Analyst Recom2.33Target Price32.00
Avg Volume829.92K52W Range18.45 - 36.66
May-16-24Upgrade BofA Securities Neutral → Buy $35 → $49
May-16-24 01:26PM Update: BofA Securities Upgrades Trupanion to Buy From Neutral, Raises Price Target to $49 From $35 (MT Newswires) +15.85%
09:34AM BofA Securities Upgrades Trupanion to Buy From Neutral, Raises Price Target to $49 From $35 (MT Newswires)
May-15-24 12:50PM Trupanion Says Ready to Provide Coverage For Feline Infectious Peritonitis Treatment in US (MT Newswires) -9.49%
09:00AM Trupanion Primed and Ready to Provide Coverage for Lifesaving Medication for Feline Infectious Peritonitis (Business Wire)
May-10-24 02:40AM Insider Buying: CEO Darryl Rawlings Acquires Shares of Trupanion Inc (TRUP) (GuruFocus.com)
May-07-24 10:00AM Trupanion Launches First Annual Veterinary Appreciation Day Awards (Business Wire) +13.51%
May-03-24 01:36PM Trupanion Shares Drop After Q1 Results, New CEO Named (MT Newswires) -16.53%
10:28AM Trupanion, Inc. (NASDAQ:TRUP) Q1 2024 Earnings Call Transcript (Insider Monkey)
07:03AM Q1 2024 Trupanion Inc Earnings Call (Thomson Reuters StreetEvents)
04:03AM Trupanion Inc (TRUP) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and ... (GuruFocus.com)
Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the Subscription Business and Other Business. The Subscription Business segment is involved in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members. The company was founded by Darryl Rawlings in 2000 and is headquartered in Seattle, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RAWLINGS DARRYLChief Executive OfficerMay 07 '24Buy24.1420,700499,663614,842May 09 06:40 PM
DREYER EMILYSVP, Channel GrowthMay 07 '24Sale25.343,12579,20119,830May 09 05:56 PM
RUBIN HOWARD EDirectorMar 31 '24Option Exercise0.005690229,405Apr 03 07:20 PM
LEVITAN DANDirectorMar 31 '24Option Exercise0.001,582095,116Apr 03 07:20 PM
Satchu ZayDirectorMar 31 '24Option Exercise0.001,58204,788Apr 03 07:20 PM
VKTX - Viking Therapeutics Inc - Stock Price Chart
TickerVKTX [NASD, RUT]
CompanyViking Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap7.62BEPS (ttm)-0.93
P/E-EPS this Y-21.98%
Forward P/E-EPS next Y-38.65%
PEG-EPS past 5Y-18.89%
P/S-EPS next 5Y40.00%
P/B8.15EPS Q/Q-6.06%
Dividend-Sales Q/Q-
Insider Own8.05%Inst Own72.67%
Insider Trans-8.76%Inst Trans-0.29%
Short Float11.94%EarningsApr 24/a
Analyst Recom1.00Target Price112.35
Avg Volume6.37M52W Range8.28 - 99.41
May-16-24Upgrade Raymond James Outperform → Strong Buy $115 → $116
May-16-24 07:00AM Tiny but Mighty: 3 Small-Cap Stocks Crushing the Russell 2000 (InvestorPlace) -11.47%
May-15-24 11:36AM Should You Hold Viking Therapeutics (VKTX) in Your Portfolio? (Zacks) +7.60%
May-14-24 07:08AM Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025 (InvestorPlace)
May-13-24 10:00AM How Viking Therapeutics Stock Could 30x (Motley Fool)
08:15AM Is Viking Therapeutics the Best Biotech Stock for You? (Motley Fool)
May-10-24 06:55AM The 3 Best Russell 2000 Stocks to Buy in May 2024 (InvestorPlace) -8.18%
May-09-24 10:34AM 7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025 (InvestorPlace)
May-08-24 01:22PM Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-07-24 02:04PM Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare (InvestorPlace)
May-06-24 03:10AM Viking Therapeutics Insider Sold Shares Worth $4,986,008, According to a Recent SEC Filing (MT Newswires)
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ZANTE GREGChief Financial OfficerMay 03 '24Option Exercise4.8634,249166,285241,610May 03 08:51 PM
ZANTE GREGChief Financial OfficerMay 03 '24Sale74.6966,7564,986,008174,854May 03 08:51 PM
Mancini MariannaChief Operating OfficerMay 01 '24Option Exercise6.18281,4251,740,575629,933May 02 09:27 PM
Mancini MariannaChief Operating OfficerMay 01 '24Sale78.66281,42522,136,474348,508May 02 09:27 PM
Lian BrianPresident & CEOFeb 09 '24Sale29.9045,0001,345,5002,139,882Feb 09 08:59 PM
W - Wayfair Inc - Stock Price Chart
TickerW [NYSE]
CompanyWayfair Inc
CountryUSA
IndustryInternet Retail
Market Cap8.37BEPS (ttm)-5.36
P/E-EPS this Y201.26%
Forward P/E31.88EPS next Y88.24%
PEG-EPS past 5Y-2.82%
P/S0.70EPS next 5Y-
P/B-EPS Q/Q35.96%
Dividend-Sales Q/Q-1.62%
Insider Own28.31%Inst Own88.06%
Insider Trans-0.78%Inst Trans-1.42%
Short Float21.79%EarningsMay 02/b
Analyst Recom1.92Target Price71.80
Avg Volume4.59M52W Range33.85 - 90.71
May-16-24Upgrade Argus Hold → Buy
May-16-24 03:01AM Katapult Holdings Inc (KPLT) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ... (GuruFocus.com)
May-13-24 12:08PM Wayfair Gaining Share in Bottoming Home Furnishings Industry, Morgan Stanley Says (MT Newswires)
06:44AM Morgan Stanley Lifts Price Target on Wayfair to $90 From $85, Sees 'Strengthening' Investment Story, Keeps Overweight Rating (MT Newswires)
May-10-24 09:50AM Here's Why Wayfair (W) is a Strong Momentum Stock (Zacks)
09:00AM Here is What to Know Beyond Why Wayfair Inc. (W) is a Trending Stock (Zacks)
May-09-24 10:00AM Value Propositions of Williams-Sonoma and Its Peers (GuruFocus.com) +6.93%
May-07-24 03:55PM From Apple to Wayfair: A Lot of Earnings Results to Cover (Motley Fool)
11:49AM Analyst Report: Wayfair Inc. (Morningstar Research)
10:14AM Beyond Stock Tanks on Weak Earnings. Rebrands Are Expensive. (Barrons.com)
May-06-24 06:07PM Beyond Posts Wider Loss Than Expected. Rebrands Are Expensive. (Barrons.com) +7.63%
Wayfair, Inc. engages in an online home furnishing store. It operates through the U.S. and International segments. The U.S. segment consists of amounts earned through product sales through the company's five distinct sites in the U.S. and through websites operated by third parties in the U.S. The International segment is composed of earnings through product sales in international sites. The company was founded by Steven K. Conine and Niraj S. Shah in May 2002 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Conine StevenCo-FounderMay 07 '24Sale68.2610,000682,588229,073May 08 06:54 PM
Shah NirajChief Executive OfficerMay 07 '24Sale68.0310,000680,330229,137May 08 06:50 PM
Schaferkordt AnkeDirectorMay 02 '24Sale58.8134820,46513,251May 03 05:24 PM
Blotner JonChief Commercial OfficerApr 15 '24Sale60.524,144250,79537,957Apr 16 08:01 PM
Conine StevenCo-FounderApr 08 '24Sale64.6210,000646,182239,073Apr 09 08:29 PM
ZIMV - ZimVie Inc - Stock Price Chart
TickerZIMV [NASD, RUT]
CompanyZimVie Inc
CountryUSA
IndustryMedical Devices
Market Cap463.38MEPS (ttm)-13.73
P/E-EPS this Y168.18%
Forward P/E22.95EPS next Y25.42%
PEG-EPS past 5Y3.36%
P/S0.70EPS next 5Y64.40%
P/B1.19EPS Q/Q74.93%
Dividend-Sales Q/Q-47.57%
Insider Own3.07%Inst Own89.92%
Insider Trans0.00%Inst Trans-0.42%
Short Float3.05%EarningsMay 08/a
Analyst Recom3.00Target Price18.00
Avg Volume337.04K52W Range6.52 - 20.91
May-16-24Upgrade Needham Hold → Buy $20
May-16-24 04:05PM ZimVie to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-12-24 09:12AM ZimVie Inc. (NASDAQ:ZIMV) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 03:03PM ZimVie Inc. (ZIMV) Reports Mixed Q1 2024 Financial Results, Misses Earnings Predictions (GuruFocus.com)
May-09-24 07:06AM Q1 2024 ZimVie Inc Earnings Call (Thomson Reuters StreetEvents) +10.34%
03:53AM ZimVie Inc (ZIMV) (Q1 2024) Earnings Call Transcript Highlights: Navigating Market Challenges ... (GuruFocus.com)
May-08-24 09:56PM ZIMV Stock Earnings: ZimVie Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:45PM ZimVie (ZIMV) Q1 2024 Earnings Call Transcript (Motley Fool)
04:05PM ZimVie Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-24-24 04:05PM ZimVie to Report First Quarter Financial Results on May 8, 2024 (GlobeNewswire)
Apr-01-24 08:00AM ZimVie Announces Closing of Sale of Spine Business (GlobeNewswire) +12.01%
Zimvie, Inc. operates as a holding company, which engages in the manufacture, design, and distribution of medical devices and surgical instruments. It operates through the Spine Products and Dental Products segments. The Spine Products segment offers spinal surgery solutions such as implants, instrumentation, biologics, and bone healing technologies to treat patients with back or neck pain caused by degenerative conditions, deformities, tumors or traumatic injury of the spine. The Dental Products segment provides dental implant solutions, biomaterial solutions, and digital dentistry. The company was founded on November 4, 2021 and is headquartered in Palm Beach Gardens, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jamali VafaSee remarks below.Apr 01 '24Option Exercise0.0021,3310259,924Apr 03 04:04 PM
Whitney Rebecca AnnSee remarks below.Mar 29 '24Option Exercise0.009,677042,706Apr 02 04:01 PM
Schneider SandraChief Accounting OfficerMar 10 '24Option Exercise0.003,591017,474Mar 11 05:31 PM
Whitney Rebecca AnnSee remarks below.Mar 10 '24Option Exercise0.004,163034,226Mar 11 05:30 PM
Kidwell HeatherSee remarks below.Mar 10 '24Option Exercise0.002,776060,046Mar 11 05:32 PM
12
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.